What is the Impact Factor of Therapeutic Advances in Medical Oncology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Therapeutic Advances in Medical Oncology is 4.10, ranking in quartile Q2 of Web of Science (SCIE).

Is Therapeutic Advances in Medical Oncology indexed in Web of Science or Scopus?

Yes, Therapeutic Advances in Medical Oncology is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.416 (Q1) and an H-index of 80.

Who publishes Therapeutic Advances in Medical Oncology and what is the Article Processing Charge (APC)?

Therapeutic Advances in Medical Oncology is published by SAGE Publications Inc.. The estimated Article Processing Charge (APC) is approximately $3,587 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Therapeutic Advances in Medical Oncology?

The official ISO-4 abbreviation of Therapeutic Advances in Medical Oncology is "THER ADV MED ONCOL". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #2,693Hybrid

Therapeutic Advances in Medical Oncology

Abbreviation (ISO):THER ADV MED ONCOL

•

Identifier (ISSN):1758-8340(Print)/1758-8359(Online)

•

Publisher:SAGE Publications Inc.

Official Website Submission Portal Compare

Clarivate IF (2026)

4.1↓ -0.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Therapeutic Advances in Medical Oncology

WoS Q2

Annual Impact Factor Metric

Current (2026):4.1

Scopus SJR & RankScopus Q1

1.416

#2,693

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

80 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate2.3%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

155articles/year

99.85% Gold OA•65.29% Original Research

Aims & Scope

Therapeutic Advances in Medical Oncology is an open access, peer-reviewed journal delivering the highest quality articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of cancer. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in medical oncology, providing a forum in print and online for publishing the highest quality articles in this area. This journal is a member of the Committee on Publication Ethics (COPE).

Topics Covered (Recognized by AI)

Medicine99.7%Biology96.6%Internal medicine96.6%Genetics94.4%Cancer85.3%Oncology82%Pathology69%Surgery58.2%Chemistry50.7%Biochemistry42.9%Chemotherapy40.4%Cancer research37.7%Immunology34.6%Bioinformatics33.5%Mathematics25.2%Clinical trial24.5%Statistics23.4%Breast cancer22.2%Gene21.6%Immune system20.6%

Primary Research Areas

Oncology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank111/333

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank142/333

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	111/333	Q2
ONCOLOGY	JCISCIE	142/333	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF4.1

Articles / Year185

Total Citations36

2025

IF4.2

Articles / Year279

Total Citations854

2024

IF4.3

Articles / Year233

Total Citations1,643

2023

IF4.9

Articles / Year180

Total Citations2,643

2022

IF5.485

Articles / Year185

Total Citations3,274

Year	Impact Factor	Articles / Year	Total Citations
2026	4.1	185	36
2025	4.2	279	854
2024	4.3	233	1,643
2023	4.9	180	2,643
2022	5.485	185	3,274
2021	8.168	166	3,741
2020	6.852	245	6,947
2019	5.67	119	5,088
2018	6.238	77	5,180
2017	—	48	2,399
2016	—	50	1,803
2015	—	28	2,839

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,693Scopus Q1SCImago Profile

Scopus Coverage:2009-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q1

1.416

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

3.95

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,587 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,422

3-Year Documents588

Citable Documents578

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 2.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

3区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Therapeutic Advances in Medical Oncology (abbr: THER ADV MED ONCOL, ISSN: 1758-8340) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by SAGE Publications Inc. in England. The periodical holds a Journal Impact Factor (JIF) of 4.10, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.416 (Q1), an H-index of 80.

The journal enforces rigorous peer evaluation with an annual output of approximately 155 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,587 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.